Weinberg Capital Partners Acquisition
Weinberg Capital Partners has made a strategic move by acquiring a majority stake in Cosmogen, a leading French producer of upscale cosmetic packaging.
The deal, finalized with MBO+, has not disclosed its financial specifics, but it aligns perfectly with Cosmogen’s ambitions to expand its global footprint and diversify its product offerings.
For 2024, the company is forecasting net sales exceeding EUR 23 million.
This acquisition represents a pivotal shift for Cosmogen as Weinberg Capital Partners—an investment firm known for focusing on small to mid-sized businesses—steps in to steer the operations of this well-regarded supplier of cosmetic applicators and packaging.
Paul Cordahi, a Director at Weinberg Capital Partners, emphasized that Cosmogen’s esteemed reputation and vast industry experience were significant factors in their decision to invest.
Growth and Expansion Plans
Looking ahead, Cosmogen anticipates a 15% increase in total net sales compared to last year, propelling its revenues beyond EUR 23 million in 2024.
The company has enjoyed a surge in demand in both European and North American markets.
This growth is attributed to acquiring new clientele, innovative product launches, and a successful introduction of primary packaging specifically designed for over-the-counter products in pharmacies.
Weinberg Capital Partners is committed to supporting Cosmogen’s expansion, with plans to enhance its global reach while also seeking out potential acquisition opportunities.
Cordahi noted that several external growth strategies have already been identified.
Innovation and Sustainability
Founded in 1982, Cosmogen has fostered numerous partnerships with beauty brands due to its flexible and innovative business model.
The company is dedicated to creating patented packaging solutions tailored to individual client needs, collaborating with manufacturing partners across Asia and Europe to generate unique designs.
Internally, Cosmogen’s Innovation & Development team is prolific, launching around thirty new registered models and generating one to two patents each year.
Allais highlighted the efficiency of the company’s fabless model, which allows for swift responses to market needs while ensuring high-quality standards throughout their supply chain.
The company manages mold production in-house, diversifying sourcing options to countries like Cambodia, the Philippines, and Vietnam.
Under Allais’s leadership, Cosmogen’s growth strategy prioritizes not just financial gains, but also the well-being of employees and sustainable innovation.
With plans to achieve EcoVadis Gold certification shortly, the company is also preparing to introduce an employee equity program, emphasizing their commitment to shared value principles.
Source: Premiumbeautynews